COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study LYW Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... The Lancet 395 (10241), 1919-1926, 2020 | 1212 | 2020 |
jmcm: An R Package for Joint Mean-Covariance Modeling of Longitudinal Data J Pan, Y Pan Journal of Statistical Software 82 (9), 1--29, 2017 | 23 | 2017 |
Circulating tumour DNA (ctDNA) in metastatic melanoma, a systematic review and meta-analysis L Gracie, Y Pan, EG Atenafu, DG Ward, M Teng, L Pallan, NM Stevens, ... European Journal of Cancer 158, 191-207, 2021 | 20 | 2021 |
UK Coronavirus Monitoring Project Team: COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study LY Lee, JB Cazier, V Angelis, R Arnold, V Bisht, NA Campton, ... Lancet 395 (10/241), 1919-1926, 2020 | 19 | 2020 |
Not all moderate disease is the same--Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity Y Pan, S Norton, JM Gwinnutt, L Kearsley-Fleet, DPM Symmons, M Lunt, ... PloS one 14 (5), e0215999, 2019 | 15 | 2019 |
The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review E Copson, AM Shaaban, T Maishman, PM Moseley, H McKenzie, ... The Breast 42, 133-141, 2018 | 8 | 2018 |
Immediate sample fixation increases circulating tumour cell (CTC) capture and preserves phenotype in head and neck squamous cell carcinoma: towards a standardised approach to … K Payne, JM Brooks, GS Taylor, N Batis, B Noyvert, Y Pan, P Nankivell, ... Cancers 13 (21), 5519, 2021 | 7 | 2021 |
jmcm: Joint Mean-Covariance Models using Armadillo and S4 J Pan, Y Pan R package version 0.1, 2016 | 3 | 2016 |
roptim: General Purpose Optimization in R using C++ Y Pan R package version 0.1 5, 2020 | 2 | 2020 |
jmcm: Joint mean-covariance models using ‘Armadillo’and S4, 2021 J Pan, Y Pan R package version 0.2 4, 0 | 2 | |
roptim: An R Package for General Purpose Optimization with C++ Y Pan, J Pan | 2* | |
Correction: not all moderate disease is the same–identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity Y Pan, S Norton, JM Gwinnutt, L Kearsley-Fleet, DPM Symmons, M Lunt, ... Plos one 15 (4), e0231481, 2020 | 1 | 2020 |
dtpcrm: Dose Transition Pathways for Continual Reassessment Method C Yap, D Slade, K Brock, Y Pan | 1 | 2019 |
Evaluation of combinatorial optimisation algorithms for c-optimal experimental designs with correlated observations SI Watson, Y Pan Statistics and Computing 33 (5), 112, 2023 | | 2023 |
SAT0110 Trajectories of functional disability in patients with early inflammatory polyarthritis and moderate disease activity: results from the early rheumatoid arthritis … S Norton, J Gwinnutt, Y Pan, D Symmons, A MacGregor, A Young, P Kiely, ... Annals of the Rheumatic Diseases 77 (Suppl 2), 917-918, 2018 | | 2018 |